The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

February 27, 2024

CALIFORNIA LEGISLATURE AND GOVERNOR ADDRESS SHORTCOMING IN PRIOR PrEP
USE AUTHORIZATION LEGISLATION 

Legislation enacted during 2019 was an initial pass at this issue but time revealed some shortcomings. The initial legislation imposed a limit of a 30-day supply; that’s now extended to 90 days if certain lab tests and follow-up care is provided. The 2019 statute did not mandate reimbursement of the pharmacist for consultations, which could take 15-30 minutes. That legislation also excluded coverage for expense of lab tests.

An additional feature of interest in the new legislative approach is the mandate that health plans and insurers cover the cost of PrEP as well as the treatment-related services provided by pharmacists, included related tests that were ordered. Please note that this legislative change relates only to the solid dosage form treatments, not the injectable form.

[California Senate Bill No. 339, approved by the Governor February 6, 2024; https://legiscan.com/CA/text/SB339/id/2832417; Allday E. California closes PrEP loophole, takes aim at HIV infection rates. San Francisco Chronicle. February 6, 2024, https://www.sfchronicle.com/health/article/prep-access-18636102.php]